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Available online 28 December 2015T cell activation involves the recognition of a foreign antigen complexed to themajor histocompatibility complex on
the antigen presenting T cell to the T cell receptor. This leads to activation of signaling pathways, which ultimately
leads to induction of key cytokine genes responsible for eradication of foreign antigens. We used the mouse EL4 T
cell as amodel system to study genes that are induced as a result of T cell activation using phorbolmyristate acetate
(PMA) and calcium ionomycin (I) as stimuli. We were also interested to examine the importance of new protein
synthesis in regulating the expression of genes involved in T cell activation. Thus we have pre-treated mouse EL4
T cells with cycloheximide, a protein synthesis inhibitor, and left the cells unstimulated or stimulated with PMA/I
for 4 h.Weperformedmicroarray expression proﬁling of these cells to correlate the gene expressionwith chromatin
state of T cells upon T cell activation [1]. Here, we detail further information and analysis of the microarray data,
which shows that T cell activation leads to differential expression of genes and inducible genes can be further clas-
siﬁed as primary and secondary response genes based on their protein synthesis dependency. The data is available in
the Gene Expression Omnibus under accession number GSE13278.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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in DMSO, followed by stimulation with phorbol myristate acetate
(PMA) and Ionomycin (I) for 4 h or are left unstimulated.xperimental
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2. Experimental design, materials and methods
2.1. Cell culture
All reagents were from Sigma-Aldrich (St Louis, MO, USA) unless
otherwise stated. EL4 T cells were cultured in RPMI 1640 medium
with 10 mM HEPES, 10% fetal calf serum (CSL, Parkville, Victoria,
Australia), 120 μg/ml penicillin, and 16 μg/ml gentamycin. Cells were
pretreated with 10 μg/ml cycloheximide (CHX) for 30 min, and then
stimulated with 10 ng/ml phorbol myristate acetate (PMA; Boehringer
Mannheim, Mannheim, Germany) and 1 μM ionomycin (I; A23187).
2.2. Total RNA isolation and puriﬁcation for microarray analysis
Total RNA was isolated from 5 × 106 cells/ml using TRI Reagent
(Sigma-Aldrich) for DMSO-treated and CHX-treated EL4 T cells,
unstimulated (0 h) or stimulated for 4 h with PMA/I as previouslythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. Correlation of genes based on their expression kinetics. Scatter plot of genes from
expression arrays categorized based on their response to CHX and PMA/I (4 h):
(a) comparing genes that were unchanged with stimulation ( ), genes that were
induced with PMA/I stimulation ( ), and genes that were inhibited by PMA/I
stimulation ( ); (b) comparing genes induced by PMA/I stimulation and not inhibited
by CHX ( ; primary response genes) and genes whose induction by PMA/I stimulation
was inhibited by CHX ( ; secondary response genes); (c) the distributions of the
average Log2 RMA values from the unstimulated cells were shown for all genes on the
array (●), genes that were unchanged with stimulation ( ), genes that were induced
with stimulation ( ), genes that were inhibited by stimulation ( ), primary response
genes ( ) and secondary response genes ( ). Genes with higher expression in DMSO
treated stimulated cells (than unstimulated, p-value b0.016 equivalent to a false
discovery rate (FDR) of b0.1) and whose expression in CHX treated stimulated cells was
not less than that in DMSO treated stimulated cells, were classiﬁed as primary response
genes. Genes with higher expression in DMSO treated stimulated cells (than
unstimulated, p-value b0.016) and with lower expression in CHX-treated, stimulated
cells (than DMSO-treated, stimulated, p-value b0.024, FDR b 0.1) were classiﬁed as
secondary response genes. Genes with p-values N0.1 for all factors (stimulation,
treatment, replicates and stimulation*treatment) were classiﬁed as unchanged genes.
Fig. 1. Categorization of expression array probes according to their kinetics of induction.
The probes on the Affymetrix Mouse Gene 1.0ST expression arrays were categorized
according to their kinetics of induction. * indicates a statistical test was used (False
Discovery Rate b 0.1). Three biological replicates for each treatment were carried out for
the expression proﬁling experiments. See text for more details.
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6R Centrifuge) for 5 min at room temperature, resuspended in 1 ml of
TRI Reagent and incubated at room temperature for at least 10 min to
allow complete dissociation of nucleoprotein complexes. 200 μL of chlo-
roformwas added and sampleswere vortexed vigorously and incubated
on ice for 15 min. The samples were then centrifuged at 13 000 rpm
(Eppendorf Centrifuge 5415 R) for 15min at 4 °C, after which the aque-
ous phase was transferred to a new 1.5 mL tube and mixed with 400 μl
of isopropanol. Samples were incubated at−70 °C overnight to precip-
itate the RNA. Then the samples were centrifuged at 13 200 rpm
(Eppendorf Centrifuge 5415 R) for 15 min at 4 °C, following which
RNA pellets were washed with 500 μl of 70% ethanol at 13 200 rpm
(Eppendorf Centrifuge 5415 R) for 15 min at 4 °C. RNA pellets were
brieﬂy air-dried and resuspended in 20 μl diethyl pyrocarbonate
(DEPC)-treatedMillipore-puriﬁedwater. The RNAwas puriﬁed another
round to generate high quality total RNA using the QIAGEN® RNeasy
Mini Kit (QIAGEN). The QIAGEN® RNeasy Mini Protocol for RNA Clean-
up was followed according to the manufacturers' instructions, with the
exception of the ﬁnal elution of total RNA was performed twice in 10–
12 μl volumes of RNase-free water (QIAGEN) with 1 min incubations
on the RNeasy® mini column (QIAGEN). RNA concentrations were de-
termined using Nanodrop® ND1000 Spectrophotometer (Nanodrop
Technologies). RNA quality was determined using an Agilent 2100
Bioanalyzer (Agilent Technologies) by checking the RNA Integrity Num-
ber and examining the electropherogram proﬁle generated.
2.3. Expression microarrays
Total RNA prepared were submitted to the ACRF/Biomolecular Re-
source Facility (JCSMR, ANU), which processed the samples by
performing the target preparation, hybridization, staining and scanning
of Affymetrix™Mouse Gene 1.0ST arrays as per manufacturers' instruc-
tions. Three biological replicates for each treatment were used for the
expression arrays. The data was analyzed using Quantile normalisation
and Robust Multichip Average (RMA) background correction adjusting
for probe sequence using the Partek Software (Partek, USA). These pro-
grams were used to generate gene expression levels from the Mouse
Gene 1.0ST arrays and an ANOVA test was used to identify genes in-
duced with PMA/I stimulation or not induced (‘unchanged’). Geneswith higher expression in DMSO treated stimulated cells (than
unstimulated, p-value b0.016 equivalent to a false discovery rate
(FDR) of b0.1) and whose expression in CHX treated stimulated cells
was not less than that in DMSO treated stimulated cells, were classiﬁed
as primary response genes. Genes with higher expression in DMSO
treated stimulated cells (than unstimulated, p-value b0.016) and with
Table 1
Number of genes in each expression bin groups.
Basal expression levels (Log 2 values)
Gene group 4–5 5–6 6–7 7–8 8–9 9–10 10–11 11–12 12–13
All 13,154 3136 1738 2050 2193 1977 1107 500 193
Up 456 275 310 395 422 380 186 80 39
Down 216 241 279 458 562 542 318 130 30
Primary 36 48 77 126 125 103 41 22 10
Secondary 240 173 176 203 204 198 102 45 18
Unchanged 5583 744 150 126 100 84 58 29 6
150 P.S. Lim et al. / Genomics Data 7 (2016) 148–151lower expression in CHX-treated, stimulated cells (than DMSO-treated,
stimulated, p-value b0.024, FDR b 0.1) were classiﬁed as secondary re-
sponse genes. Genes with p-values N0.1 for all factors (stimulation,
treatment, replicates and stimulation ∗ treatment)were classiﬁed as un-
changed genes. Groups were then subdivided further depending on
their average basal expression level. Raw and normalized data have
been deposited in the NCBI Gene Expression Omnibus (GEO) under ac-
cession number GSE13278.3. Discussion
3.1. Categorisation of gene probes on expression arrays
Expression proﬁling was performed on non-stimulated or PMA/I-
treated (4 h) EL4 T cells with or without cycloheximide (CHX) treatment,
and inducible genes were identiﬁed. 2727 probes were signiﬁcantly
(False Discovery Rate (FDR) b 0.1) induced with PMA/I stimulation for
4 h (in DMSO treated cells) and were thus classiﬁed as induced or ‘Up
with Stimulation’, while 2971 were signiﬁcantly down-regulated or
‘Down with Stimulation’ (FDR b 0.1) and 7357 had p values N0.2 for
both the drug (CHX/DMSO) and stimulation factors and thus were classi-
ﬁed as ‘unchanged’ (Fig. 1). Of the induced probes, 645 had an average
level of expression in stimulated CHX treated cells that was equal to or
higher than the level of expression in stimulated DMSO treated cells
and thesewere classiﬁed as ‘primary response genes’. 1454 of the induced
probes were signiﬁcantly (FDR b 0.1) less in CHX stimulated cells than
DMSO stimulated cells and these were classiﬁed as secondary response
genes. It should be noted that some induced probes were on average
less in CHX stimulated cells than DMSO stimulated cells but not signiﬁ-
cantly so and thus were not classiﬁed.Fig. 3. Density plot of the basal expression values for the different gene groups identiﬁed
with expression microarrays. EL4 T cells were stimulated with PMA/I for 4 h with and
without pre-treatment with cycloheximide (CHX). Expression microarrays were
performed with RNA from these cells (3 biological replicates per treatment) and genes
were grouped according to the kinetics of their response. The distributions of the
average Log2 RMA values from the unstimulated cells are shown for all genes on the
array (black line), genes that were unchanged with stimulation (green line), genes that
were induced with stimulation (purple line), genes that were inhibited by stimulation
(yellow line), genes induced by stimulation and not inhibited by CHX (red line) and
genes whose induction by stimulation was inhibited by CHX (blue line).3.2. Distribution of genes based on basal expression values and protein
synthesis requirement
In order to conﬁrm that the genes are grouped correctly according to
their response to PMA/I and CHX treatment, the genes were scattered
based on their basal mRNA expression levels (in log2) to examine the
distribution of genes based on their response to PMA/I and/or CHX in
a graphicalmanner. In general, therewas a spread of genes from lowex-
pression level to high expression level for the different groups of genes
with most genes showing less than 2 fold change (Fig. 2a and b, be-
tween the two black lines, Table 1). Genes in which expression is in-
duced upon PMA/I stimulation and genes that are inhibited by PMA/I
stimulation were distributed accordingly with the unchanged genes
that were distributed in between the genes that change with stimula-
tion as expected (Fig. 2a). The primary response genes are distributed
separately from secondary response genes thus these genes are classi-
ﬁed correctly (Fig. 2b). Finally all the different groupings of genes
were also plotted in a scatter plot to compare the distribution of all
the different groupings based on the differences in expression levels
when genes are stimulated with PMA/I and treated with CHX. The dif-
ferent groups of genes are distributed as expected and separately from
each other (Fig. 2c). Thus, the different groups of genes selected and
classiﬁed from the expression proﬁling show the expected distribution
proﬁles and are classiﬁed accurately.
From the scatterplot proﬁles, there seems to be a variation in the dis-
tribution of genes across the different basal expression levels (Fig. 2a
and b). To examine how the different gene groups are distributed
based on the basal expression levels, a density plot of the number of
genes within a certain basal expression level was generated (Fig. 3).
Both the primary and secondary response gene groups displayed a
wide spread of basal mRNA expression levels but on average the basal
expression levels are higher compared with the unchanged group or
all genes, suggesting that many inducible genes are already producing
detectable transcripts (Fig. 3). Genes with different basal expression
levels may display distinct basal chromatin characteristics. Therefore,
to ensure comparison of genes with similar basal expression levels,
the gene groups were binned according to their basal mRNA expression
levels (Table 1). The number of primary response genes in the lowest
expression bin (log2 3–4) was small and thus could not be treated in a
sound statistical manner (data not shown).
Thus, inducible genes were categorized into primary and secondary
response genes and further grouped according to their basal mRNA ex-
pression level, creating a grid of gene groups that can be used for com-
parison of epigenomic marks. This grouping of genes is important for
comparing chromatin states as increasing basal expression level is asso-
ciated with an increase in the levels of the histone modiﬁcations and
RNA polymerase II suggesting that the levels of these factors correlate
with transcriptional activity [1,3–5]. In summary, T cell activation
leads to differential expression of genes and inducible genes can be clas-
siﬁed as primary response and secondary response based on their de-
pendency on protein synthesis.Conﬂicts of interest
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